Ligand Pharmaceuticals Inc logo

Ligand Pharmaceuticals Inc

NEW
FRA:LGDN (USA)   Ordinary Shares - Class B
€ 244 -2 (-0.81%) Aug 19
31.12
P/B:
5.99
Market Cap:
€ 5.01B ($ 5.85B)
Enterprise V:
€ 4.80B ($ 5.60B)
Volume:
35.00
Avg Vol (2M):
28.00
Trade In:

Ligand Pharmaceuticals Inc Valuation Measures